External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

EURETINA 2025

-
Coming soon
06:00 AM
Duration 10mins Palais des Congrès
Quantitative Ultra-Widefield Fluorescein Angiography for the Assessment of Novel Biomarkers of Vascular Stability With Faricimab▼: A YOSEMITE/RHINE Post Hoc Analysis
Justis Ehlers, Matar K, Indurkar A, Della Vecchia L, Amine R, Mamone J, Tang A, Gibson K, Dagincourt N, Mar F, Amador M, Warter A, Sim D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
RHONE-X Extension Study: Clinical Improvements in Eyes With DME Switched From Aflibercept to Faricimab▼
Ian Pearce, Starr M, Sheth V, Khanani A, Jones C, Gibson K, Lai T, Schlottmann P, Sim D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
Treatment Response and Safety of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Steve Huddleston, Emanuelli A, Amador M, Brown J, Coney J, Cunningham M, Gonzalez L, Scott A, Milunovich S, Yang M, Lu X-Y

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
Real-World Clinical and Anatomical Outcomes With Faricimab▼ in Patients With DME From a Global, Prospective Observational Study: The VOYAGER Study
Koh A, Schmitz-Valckenberg S, Bailey C, Chaudhary V, Chi G, Downey A, Schweitzer J, Finger R, Parravano M, Sheth V, Kardatzke D, Robyn Guymer

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
Effectiveness and Safety of Faricimab▼ in Eyes With DME Beyond Year 1: Results From the UK FARWIDE-DME Study
Kiire C, Ian Pearce, Peto T, Sivaprasad S, Reynolds R, Bailey C, Downey L, Chi G, James N, Downey A, Dodds M, Dayal P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
Faricimab▼ for Angioid Streaks in Japan: Week 12 Results From NIHONBASHI
Tomohiro Iida, Akitaka Tsujikawa, Hideki Koizumi, Ryusaburo Mori, Haruka Ochi, Junko Sato, Keisuke Iwasaki

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
The APAC Vision Health Survey Report: An urgent challenge and a critical conjunction
Wei Kiong Ngo, Andrew Chang, Marten Brelen, Kenneth Fong, Harvey Uy, Gavin Tan, Seung-Young Yu, Chi Chun Lai, Paisan Ruammviboonsuk, Shilpika Das, Rancy Khosla

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
Assessing a 36-Week Refill-Exchange Regimen for the PDS in Patients With Up To 2 Years Diagnosis of nAMD: Phase 3b Sightspire Trial
Holz F, Khanani A, Paudel N, Zinkernagel M, Dakouras A, Foxton R, Dena Howard, Liu B, Scheidl S, Tian K

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
The Impact of Improvements to Surgical Procedure on the Incidence of Endophthalmitis and Associated Outcomes of Patients in the PDS Clinical Development Programme
Cheung G, Chang M, Chaudhry N, Campochiaro P, Chang M, Pieramici P, Regillo C, Bobbala A, Gune S, Jaycock P, Kardatzke D, Prager A, Singh N

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Palais des Congrès
The Phase 1/2 Burgundy Study of Zifibancimig Administered via Intravitreal Injection and the PDP in Patients With nAMD: Rationale and Study Design
Graff J, Wolfe J, Haug S, Dhoot D, Kim J, Kwong M, Callaway N, Orduna J, Steiert B, Wollenhaupt M, Wentzel C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:51 AM
Duration 6mins Palais des Congrès
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema at 1 and 2 Years: A Systematic Literature Review and Network Meta-Analysis
Jakob Siedlecki, Barakat M, Buehrer C, Cox O, Gibson K, Holekamp N, Mar F

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:09 AM
Duration 6mins Palais des Congrès
Impact of Continuous Ranibizumab Delivery via the PDS on Nonperfusion and Vascular Leakage in Eyes With Diabetic Retinopathy or Diabetic Macular Edema
Couturier A, Gill M, Balaratnasingam C, Emanuelli A, Suner I, Dakouras A, Latkany P, Plenty A, Gune S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:15 AM
Duration 6mins Palais des Congrès
Impact of Continuous vs Treatment in Bilateral DME: Efficacy and Safety Outcomes in PDS-Treated Study Eyes vs Anti-VEGF Injection-Treated Fellow Eyes in the Pagoda Trial
Udaondo P, Eichenbaum D, Graff J, Hsieh YT, Hsu J, Wirthlin R, Blotner S, Gune S, Heinrich D, Jones M, Santhanankrishnan A, Schimpl A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:21 AM
Duration 6mins Palais des Congrès
Predictors of Extended Treatment Intervals in Patients With DME Treated With Faricimab▼ in the Phase 3 YOSEMITE/RHINE Trials
Bianca Gerendas, Ambresin A, Arevalo JF, Gibson K, Sim D, Yang M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:33 AM
Duration 6mins Palais des Congrès
Retinal Fluid and Thickness Fluctuations in Patients With Diabetic Macular Edema: Impact of Continuous Delivery of Ranibizumab With the PDS From the Pagoda Trial Through Year 2
Eter N, Awh C, Hatz K, Marcus D, Tan G, Blotner S, Eghoej M, Gordon A, Heinrich D, Menezes A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:39 AM
Duration 6mins Palais des Congrès
Automated Quantification of Retinal Fluid in Patients With Diabetic Macular Edema: Analysis of Faricimab▼ vs Aflibercept in YOSEMITE/RHINE
Gavin Tan, Albrecht T, Lu H, Litts KM, Yang M, Holekamp N

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:30 AM
Duration 60mins Paris, France
Access the presentation from the EURETINA symposium "Real-world decisions with real-world data"
Khanani A, Mitchell P, Sivachandran N, Hamilton R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:42 PM
Duration 6mins Palais des Congrès
Reduced Hard Exudates and Microaneurysms With Faricimab▼ Compared With Aflibercept in YOSEMITE/RHINE Using Automated Segmentation of DME Lesions on Colour Fundus Photography
Andreas Pollreisz, Sim D, Yang M, Benech AC, Gibson K, Benmansour F

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:45 AM
Duration 60mins Paris, France
View the EURETINA symposium "THROUGH OUR PATIENTS’ EYES: Patient voices in the era of continuous drug delivery for retinal disease"
Awh C, Becker M, Pieramici D, Dolz-Marco R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:00 AM
Duration 6mins Palais des Congrès
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Eric Souied, Bakall B, Koh A, Tan C, Vakharia P, Yang M, Patel S, Margaron P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:45 AM
Duration 60mins Paris, France
Access the presentation from the EURETINA symposium "The nAMD Challenge: Looking Beyond VEGF-A Inhibition"
Holz F, Koh A, Sheth V, Couturier A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:45 PM
Duration 6mins Palais des Congrès
Faricimab▼ for Polypoidal Choroidal Vasculopathy: 1-Year Results From the Phase 3b/4 SALWEEN Trial
Tim Lai, Chen SJ, Cheung G, Iida T, Koh A, Lee J, Lee WK, Li X, Ruamviboonsuk P, Sun X, Yanagi Y, Bai R, Duc AN, Margaron P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:51 PM
Duration 6mins Palais des Congrès
Effectiveness and Safety of Faricimab▼ in nAMD Eyes Beyond Year 1: Results From the UK FARWIDE-nAMD Study
Gabriella De Salvo, Varma D, Talks J, Patel P, De Silva S, Gale R, Mckibbin M, Chi G, James N, Downey A, Dodds M, Dayal P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:15 PM
Duration 6mins Palais des Congrès
Machine Learning–Based 3D Volumetric Analysis of Pigment Epithelial Detachment Reduction With Faricimab▼ vs Aflibercept in TENAYA/LUCERNE
Paolo Lanzetta, Yonekawa Y, Albrecht T, Harrell E, Hibar D, Lu H, Patel S, Yang M, Margaron P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:27 PM
Duration 6mins Palais des Congrès
Real-World Treatment Patterns and Ocular Morbidity in Patients with Uveitic Macular Oedema (UME) Secondary to Non-Infectious Uveitis (NIU) in the United States (US)
Rachael Harlow, Quan Dong Nguyen, Jia-Horung Hung, Lu Chen, Parul Dayal, Navdeep Pal, Ivaylo Stoilov, Marina Mesquida, Zdenka Haskova, Laura Steeples

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:39 PM
Duration 6mins Palais des Congrès
Greater Anatomical Improvements With Faricimab▼ vs Aflibercept 8 Weeks After Injections: A TENAYA/LUCERNE Post Hoc Analysis
Varun Chaudhary, Avni Finn, Nicholas Dagincourt, Shriji Patel, Philippe Margaron

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 6mins Palais des Congrès
Real-World Clinical and Anatomical Outcomes With Faricimab▼ in Patients With nAMD From a Global, Prospective Observational Study: The VOYAGER Study
Robyn Guymer, Schmitz-Valckenberg S, Bailey C, Chaudhary V, Chi G, Downey A, Schweitzer J, Finger R, Koh A, Parravano M, Sheth V, Kardatzke D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:15 PM
Duration 6mins Palais des Congrès
Four-Year Outcomes of Faricimab▼ in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial
Veeral Sheth, Shriji Patel, Arshad M. Khanani, Marta S. Figueroa, Robyn Guymer, Timothy Y. Y. Lai, Andrew Lotery, Patricio Schlottmann, Charles C. Wykoff, Ruobing Bai, Philippe Margaron, Yannan Tang, Aachal Kotecha

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:15 AM
Duration 60mins Paris, France
Access the presentation from the EURETINA symposium "Advocating for innovative therapies: Everything you need to know"
Pearce I, Grimaldi G, Gallego-Pinazo R, Husereau D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 AM
Duration 60mins Paris, France
Access the presentation from the EURETINA symposium "The DME Challenge: Looking Beyond VEGF-A Inhibition"
Sadda S, Vujosevic S, Chaudhary V, Pearce I

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:39 PM
Duration 6mins Palais des Congrès
Pigment Epithelial Detachment Thickness Fluctuations in the Phase 3 Archway Trial of the PDS in Neovascular Age-Related Macular Degeneration
Kodjikian L, Brodie F, Graff J, Lai T, Malik D, Ruiz-Medrano J, Priglinger S, Blotner, Gordon A, Holekamp N, Prager, A Heinrich D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:45 PM
Duration 6mins Palais des Congrès
First-Time Long-Term Efficacy and Safety Outcomes of PDS Patients Enrolled in the Ladder Phase 2 Trial of PDS for nAMD Followed for up to ~7 Years
Khanani A, Mittra R, Awh C, Regillo C, Blotner S, Gune S, Heinrich D, Le Pogam S, Yaqub M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:51 PM
Duration 6mins Palais des Congrès
Five-Year Efficacy and Safety Outcomes in Patients With Neovascular Age-Related Macular Degeneration Enrolled in the Archway Study and Treated With the PDS
Graff J, Kitchens J, Andrea-Thanei G, Blotner S, Gune S, Rabena M, Singh N

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:54 PM
Duration 6mins Palais des Congrès
Association of Early Macular Leakage Resolution With Extended Dosing Intervals in Patients With RVO: A BALATON/COMINO Post Hoc Analysis
Christiana Dinah, Danzig C, Bhatt H, Dagincourt N, Pereira LP, Schweitzer J, Thommen J

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar